321 related articles for article (PubMed ID: 28894365)
21. Tumor-triggered drug release from calcium carbonate-encapsulated gold nanostars for near-infrared photodynamic/photothermal combination antitumor therapy.
Liu Y; Zhi X; Yang M; Zhang J; Lin L; Zhao X; Hou W; Zhang C; Zhang Q; Pan F; Alfranca G; Yang Y; de la Fuente JM; Ni J; Cui D
Theranostics; 2017; 7(6):1650-1662. PubMed ID: 28529642
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of caveolin-1 in inflammatory breast cancer cells enables IBC-specific gene delivery and prodrug conversion using histone-targeted polyplexes.
Ross NL; Sullivan MO
Biotechnol Bioeng; 2016 Dec; 113(12):2686-2697. PubMed ID: 27241022
[TBL] [Abstract][Full Text] [Related]
23. Intelligent Photosensitive Mesenchymal Stem Cells and Cell-Derived Microvesicles for Photothermal Therapy of Prostate Cancer.
Huang L; Xu C; Xu P; Qin Y; Chen M; Feng Q; Pan J; Cheng Q; Liang F; Wen X; Wang Y; Shi Y; Cheng Y
Nanotheranostics; 2019; 3(1):41-53. PubMed ID: 30662822
[TBL] [Abstract][Full Text] [Related]
24. Near-infrared-absorbing gold nanopopcorns with iron oxide cluster core for magnetically amplified photothermal and photodynamic cancer therapy.
Bhana S; Lin G; Wang L; Starring H; Mishra SR; Liu G; Huang X
ACS Appl Mater Interfaces; 2015 Jun; 7(21):11637-47. PubMed ID: 25965727
[TBL] [Abstract][Full Text] [Related]
25. Near-infrared photothermal therapy using EGFR-targeted gold nanoparticles increases autophagic cell death in breast cancer.
Zhang M; Kim HS; Jin T; Moon WK
J Photochem Photobiol B; 2017 May; 170():58-64. PubMed ID: 28390259
[TBL] [Abstract][Full Text] [Related]
26. Plasmonic titanium nitride nanoparticles for in vivo photoacoustic tomography imaging and photothermal cancer therapy.
He W; Ai K; Jiang C; Li Y; Song X; Lu L
Biomaterials; 2017 Jul; 132():37-47. PubMed ID: 28407493
[TBL] [Abstract][Full Text] [Related]
27. Intracellular Assembly of Nuclear-Targeted Gold Nanosphere Enables Selective Plasmonic Photothermal Therapy of Cancer by Shifting Their Absorption Wavelength toward Near-Infrared Region.
Panikkanvalappil SR; Hooshmand N; El-Sayed MA
Bioconjug Chem; 2017 Sep; 28(9):2452-2460. PubMed ID: 28837765
[TBL] [Abstract][Full Text] [Related]
28. Inherently stealthy and highly tumor-selective gold nanoraspberries for photothermal cancer therapy.
Gandra N; Portz C; Nergiz SZ; Fales A; Vo-Dinh T; Singamaneni S
Sci Rep; 2015 May; 5():10311. PubMed ID: 25974150
[TBL] [Abstract][Full Text] [Related]
29. Human Adipose-Derived Stem Cells Labeled with Plasmonic Gold Nanostars for Cellular Tracking and Photothermal Cancer Cell Ablation.
Shammas RL; Fales AM; Crawford BM; Wisdom AJ; Devi GR; Brown DA; Vo-Dinh T; Hollenbeck ST
Plast Reconstr Surg; 2017 Apr; 139(4):900e-910e. PubMed ID: 28350664
[TBL] [Abstract][Full Text] [Related]
30. Bioproduction of gold nanoparticles for photothermal therapy.
Silva CO; Rijo P; Molpeceres J; Ascensão L; Roberto A; Fernandes AS; Gomes R; Pinto Coelho JM; Gabriel A; Vieira P; Reis CP
Ther Deliv; 2016; 7(5):287-304. PubMed ID: 27075950
[TBL] [Abstract][Full Text] [Related]
31. Dual plasmonic gold nanostars for photoacoustic imaging and photothermal therapy.
Raghavan V; O'Flatharta C; Dwyer R; Breathnach A; Zafar H; Dockery P; Wheatley A; Keogh I; Leahy M; Olivo M
Nanomedicine (Lond); 2017 Mar; 12(5):457-471. PubMed ID: 28181456
[TBL] [Abstract][Full Text] [Related]
32. Plasmonic Gold Nanostar-Mediated Photothermal Immunotherapy.
Odion RA; Liu Y; Vo-Dinh T
IEEE J Sel Top Quantum Electron; 2021; 27(5):. PubMed ID: 34054285
[TBL] [Abstract][Full Text] [Related]
33. Multifunctional hybrid nanopatches of graphene oxide and gold nanostars for ultraefficient photothermal cancer therapy.
Nergiz SZ; Gandra N; Tadepalli S; Singamaneni S
ACS Appl Mater Interfaces; 2014 Sep; 6(18):16395-402. PubMed ID: 25152960
[TBL] [Abstract][Full Text] [Related]
34. Unexpected high photothemal conversion efficiency of gold nanospheres upon grafting with two-photon luminescent ruthenium(II) complexes: A way towards cancer therapy?
Zhang P; Wang J; Huang H; Yu B; Qiu K; Huang J; Wang S; Jiang L; Gasser G; Ji L; Chao H
Biomaterials; 2015 Sep; 63():102-14. PubMed ID: 26093791
[TBL] [Abstract][Full Text] [Related]
35. Gold nanorod embedded reduction responsive block copolymer micelle-triggered drug delivery combined with photothermal ablation for targeted cancer therapy.
Parida S; Maiti C; Rajesh Y; Dey KK; Pal I; Parekh A; Patra R; Dhara D; Dutta PK; Mandal M
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3039-3052. PubMed ID: 27721046
[TBL] [Abstract][Full Text] [Related]
36. Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.
Eckhardt BL; Gagliardi M; Iles L; Evans K; Ivan C; Liu X; Liu CG; Souza G; Rao A; Meric-Bernstam F; Ueno NT; Bartholomeusz GA
PLoS One; 2018; 13(5):e0195932. PubMed ID: 29768500
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancer.
Aggarwal N; Santiago AM; Kessel D; Sloane BF
Breast Cancer Res Treat; 2015 Nov; 154(2):251-62. PubMed ID: 26502410
[TBL] [Abstract][Full Text] [Related]
38. In vivo volumetric photoacoustic molecular angiography and therapeutic monitoring with targeted plasmonic nanostars.
Nie L; Wang S; Wang X; Rong P; Ma Y; Liu G; Huang P; Lu G; Chen X
Small; 2014 Apr; 10(8):1585-93, 1441. PubMed ID: 24150920
[TBL] [Abstract][Full Text] [Related]
39. In vitro vascularized tumor platform for modeling tumor-vasculature interactions of inflammatory breast cancer.
Gadde M; Phillips C; Ghousifam N; Sorace AG; Wong E; Krishnamurthy S; Syed A; Rahal O; Yankeelov TE; Woodward WA; Rylander MN
Biotechnol Bioeng; 2020 Nov; 117(11):3572-3590. PubMed ID: 32648934
[TBL] [Abstract][Full Text] [Related]
40. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
